Sunshine Biopharma Inc. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
Sunshine Biopharma Inc. (SBFM) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2021-03-30
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-09-30 was $0.00.
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-06-30 was $0.00.
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2020-03-31 was $0.00.
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2019-09-30 was $0.00.
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2020 was $0.00.
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2019 was -$0.05, a 600.00% decline from fiscal 2018.
- Sunshine Biopharma Inc. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2018 was $0.01.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 10-Q/A · filed 2020-08-31 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | |||
| 2019-12-31 | -$0.05 10-K · filed 2021-03-30 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | -$0.13 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$0.12 10-Q/A · filed 2020-08-31 | -$0.13 10-Q/A · filed 2020-08-31 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-18 | |||
| 2018-12-31 | $0.01 10-K · filed 2020-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |